As reported last week, the billionaire founder of Insys Therapeutics Inc. (NASDAQ:INSY) was arrested on charges related to his participation in an alleged scheme to bribe doctors into prescribing unqualified patients the company's fentanyl-based pain drug that is intended for cancer patients.
As shares of INSY remain halted at $5.74 per share, investors and traders are wondering when to expect the resumption of trading.
This morning, Insys announced that subsequent to the trading hold placed on its stock on Thursday after market close, the company received a series of questions on Friday from NASDAQ. "Those questions have been addressed, and the company is awaiting response from NASDAQ regarding the resumption of trading."
We'll be sure to update readers with updates as soon as they are available. Be sure to subscribe to one or more of our free e-mail newsletters so you never miss an important marijuana stock update. Also, don't forget to connect with The Daily Marijuana Observer on social media via Facebook, Twitter, StockTwits, YouTube, and Instagram.